Targeted Alpha Therapy Market Size to Hit USD 11.52 Billion by 2035 from USD 1.25 Billion in 2025 at CAGR of 24.9% - SNS Insider
U.S. Market to Reach USD 4.05 Billion, Europe USD 3.37 Billion by 2035 as Actinium-225 Pipeline Expansion and PSMA-Targeted Radioligand Therapies Fuel Growth.Austin, United States, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Targeted Alpha Therapy Market Size & Growth Analysis: According to SNS Insider, The Targeted Alpha Therapy Market size was valued at USD 1.25 Billion in 2025 and is expected to reach USD 11.52 Billion by 2035, growing at a CAGR of 24.9% from 2026 to 2035. Demand is rising as high-ene
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.